Concepedia

Yuhong Ning

YN

14

Publications

1.9K

Citations

14

H-Index

2006

Active since

Affiliations

Bristol-Myers Squibb (Switzerland)(Current)

California Institute of Technology

University of California, San Francisco

UCSF Helen Diller Family Comprehensive Cancer Center

ID Genomics (United States)

Yuhong Ning is an author at Bristol-Myers Squibb (Switzerland) specializing in medicine, cell biology, and tumor microenvironment.

Top concepts

Publications per year

2006–2024

14

Publications

14

Immunomodulatory agents lenalidomide and pomalidomide co‐stimulate <scp>T</scp> cells by inducing degradation of <scp>T</scp> cell repressors <scp>I</scp> karos and <scp>A</scp> iolos via modulation of the <scp>E</scp> 3 ubiquitin ligase complex <scp>CRL</scp> 4 <scp> <sup>CRBN</sup> </scp>

Anita K. Gandhi, Jian Kang, Courtney G. Havens et al. · British Journal of Haematology · 2013 · 611 citations · Full text

A Comparison of Azacitidine and Decitabine Activities in Acute Myeloid Leukemia Cell Lines

Paul W. Hollenbach, Aaron Nguyen, Helen Brady et al. · PLoS ONE · 2010 · 354 citations · Full text

A human tissue map of 5-hydroxymethylcytosines exhibits tissue specificity through gene and enhancer modulation

Xiaolong Cui, Ji Nie, Jeremy Ku et al. · Nature Communications · 2020 · 213 citations · Full text

Rate of CRL4CRBN substrate Ikaros and Aiolos degradation underlies differential activity of lenalidomide and pomalidomide in multiple myeloma cells by regulation of c-Myc and IRF4

Chad C. Bjorklund, Ling Lu, Jian Kang et al. · Blood Cancer Journal · 2015 · 211 citations · Full text

Detection of early stage pancreatic cancer using 5-hydroxymethylcytosine signatures in circulating cell free DNA

Gulfem D. Guler, Yuhong Ning, Chin‐Jen Ku et al. · Nature Communications · 2020 · 177 citations · Full text

Rows per page

1–5 of 14